10X Genomics Inc (NASDAQ:TXG)
| 102.80 Delayed Data As of Aug 14 |  -1.97 / -1.88%Today’s Change | 45.11 Today|||52-Week Range 108.36 | +34.82% Year-to-Date |
Latest TXG News | Press Releases
| 10x Genomics Enjoys Investor Support As Stock Rebounds Aug 14 / Seeking Alpha - Paid Partner Content | 10x Genomics - Growing One Cell At A Time Jul 27 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 104.77 |
| Today’s open | 103.50 |
| Day’s range | 101.01 - 103.77 |
| Volume | 19,859 |
| Average volume (3 months) | 795,283 |
| Market cap | $9.5B |
Data as of 3:59pm ET, 08/14/2020
Growth & Valuation
| Earnings growth (last year) | +72.48% |
| Earnings growth (this year) | -41.09% |
| Earnings growth (next 5 years) | +43.00% |
| Revenue growth (last year) | +68.06% |
| P/E ratio | NM |
| Price/Sales | 29.84 |
| Price/Book | 22.02 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$0.31 |
| Annual revenue (last year) | $245.9M |
| Annual profit (last year) | -$31.3M |
| Net profit margin | -12.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
